Oishi, Naoya
Nomoto, Masanori
Ohkawa, Noriaki
Saitoh, Yoshito
Sano, Yoshitake
Tsujimura, Shuhei
Nishizono, Hirofumi
Matsuo, Mina
Muramatsu, Shin-ichi
Inokuchi, Kaoru
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (JP25115002)
Japan Society for the Promotion of Science (JP23220009, JP18H05213, JP16H04653, JP17K19445)
Core Research for Evolutional Science and Technology (JPMJCR13W1)
Precursory Research for Embryonic Science and Technology (JPMJPR1684)
Mitsubishi Foundation
Uehara Memorial Foundation
Takeda Science Foundation
Hokuriku Bank
Tamura Science and Technology Foundation
Narishige Neuroscience Research Foundation
Article History
Received: 25 October 2018
Accepted: 26 December 2018
First Online: 8 January 2019
Ethics approval
: All procedures involving the use of animals complied with the guidelines of the National Institutes of Health and were approved by the Animal Care and Use Committee of the University of Toyama.
: Not applicable.
: S.M. owns equity in a company (Gene Therapy Research Institution) that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, S.M. has a conflict of interest. The other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.